Edition:
United States

Fluidigm Corp (FLDM.OQ)

FLDM.OQ on NASDAQ Stock Exchange Global Select Market

6.04USD
15 Dec 2017
Change (% chg)

$-0.07 (-1.15%)
Prev Close
$6.11
Open
$6.12
Day's High
$6.28
Day's Low
$5.85
Volume
653,769
Avg. Vol
76,037
52-wk High
$8.68
52-wk Low
$2.52

Chart for

About

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing... (more)

Overall

Beta: 3.37
Market Cap(Mil.): $233.43
Shares Outstanding(Mil.): 38.65
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Fluidigm posts Q3 adj. loss per share $0.25​

* Fluidigm announces third quarter financial results and operational progress

Nov 02 2017

BRIEF-Fluidigm enters into distribution agreement with University Of Zurich

* Fluidigm Corp - ‍ Entered into a distribution agreement with University Of Zurich to offer histocat software for multiparameter tissue analysis​ Source text for Eikon: Further company coverage:

Oct 24 2017

BRIEF-Neuberger Berman Group LLC reports 13.65 percent passive stake in Fluidigm

* Neuberger Berman Group LLC reports a 13.65 percent passive stake in Fluidigm Corp as of August 31, 2017 - sec filing‍​ Source text : [ID:http://bit.ly/2eL1ifW] Further company coverage:

Sep 08 2017

BRIEF-Fluidigm enters into licensing agreement with Baylor Genetics

* Fluidigm Corp - co, ‍ Baylor Genetics announced they have entered into a licensing agreement​

Aug 17 2017

BRIEF-Fluidigm announces sale of $30 mln of common stock in at-the-market equity offering

* Fluidigm announces sale of $30 million of common stock in at-the-market equity offering

Aug 10 2017

BRIEF-Fluidigm posts Q2 loss per share $0.58

* Fluidigm announces second quarter financial results and operational progress

Aug 03 2017

BRIEF-Fluidigm Corp announces termination of tax benefit preservation plan

* Fluidigm corporation announces termination of tax benefit preservation plan

Aug 02 2017

BRIEF-Fluidigm, Ascendas Genomics announce strategic partnership

* Fluidigm and Ascendas Genomics announce strategic partnership to develop microfluidic molecular diagnostics in China

Jul 27 2017

Earnings vs. Estimates